Company Summary: Merus N.V.

Overview:

• Merus N.V. is a biotechnology company based in the Netherlands.
• The company focuses on developing innovative cancer immunotherapies, particularly antibody-based treatments.

Operational Details:

• Location: Utrecht, The Netherlands (Uppsalalaan 17, 3584 CT Utrecht)
• Primary Exchange & Symbol: Nasdaq Global Market, trading under the symbol MRUS
• Shares Outstanding: 69,090,469 as of February 21, 2025
• Market Capitalization (as of June 30, 2024): Approximately $3,996.5 million

Corporate Structure:

• The company is incorporated and organized under Dutch law.
• It is a large accelerated filer, indicating a substantial public company status.

Employees, Revenue, Income:

• The document does not specify the number of employees.
• Financial details such as revenue and income are not provided in this excerpt.

Business Focus:

• Merus develops human monoclonal antibody therapies using its proprietary Biclonics® platform.
• The company's therapies are aimed at treating various cancers by engaging the immune system to target and destroy tumor cells.
• It operates through collaborations, licensing agreements, and its own R&D initiatives.

Regulatory & Reporting:

• The company complies with SEC reporting requirements, having filed its annual report on Form 10-K/A.
• It has an insider trading compliance policy in place but no specific financial results or customer count are disclosed.

Key Agreements and Policies:

• It has various material contracts related to collaboration, licensing, and financing.
• The company maintains a list of subsidiaries and has engaged major accounting firms such as KPMG for audits.

Additional Information:

• The company emphasizes internal controls and adherence to Sarbanes-Oxley regulations.
• The document mentions no financial statements are included in this amendment; details on revenue, net income, or customer numbers are not included.

Note: The provided document largely contains regulatory, corporate, and legal disclosures and does not specify detailed operational metrics such as number of customers, employee count, revenue, or net income.